Brain presses on with €35m bio IPO despite rough markets

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Brain presses on with €35m bio IPO despite rough markets

Brain 230x150

Biotechnology Research And Information Network, the German biotech business, has set a price range of €9 to €12 a share for its Frankfurt listing, implying a market cap of €148m to €197m.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article